Summary:
- The article discusses the challenges faced by federally funded scientists in conducting research on marijuana due to its Schedule I classification under federal law.
- Schedule I substances are considered to have a high potential for abuse and no accepted medical use, which creates a paradox for researchers who want to study the potential medical benefits of marijuana.
- The article highlights the need for regulatory changes to make it easier for researchers to access and study marijuana, which could lead to a better understanding of its potential therapeutic applications.